Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Dage

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Journal of Cardiovascular Pharmacology|November 1, 1994
Effects of MDL 28,133A, a 5-HT2 receptor antagonist, on platelet aggregation and coronary thrombosis in dogsC P Hsieh, K Sakai, G C Bruns, et al.
Journal of Enzyme Inhibition|January 1, 1989
Interaction of angiotensin I-converting enzyme with two potent tricyclic inhibitorsE Giroux, D W Beight, R C Dage, et al.
The American Journal of Physiology|April 1, 1989
Mitogenesis by serum and PDGF is independent of PI degradation and PKC in VSMCM Kihara, P J Robinson, S H Buck, et al.
Journal of Cardiovascular Pharmacology|February 1, 1987
Effects of enoximone and isobutylmethylxanthine on contractile tension and cyclic nucleotide levels in isolated blood-perfused dog papillary muscleC P Hsieh, T Kariya, R C Dage, et al.
The American Journal of Physiology|December 1, 1991
Parathyroid hormone: an endogenous modulator of cardiac calcium channelsD Rampe, A E Lacerda, R C Dage, et al.
Journal of Cardiovascular Pharmacology|July 1, 1985
Studies on the mechanism of the positive inotropic effect of piroximone in cat papillary muscleH C Cheng, T Kariya, E M Gleason, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
High affinity [3H]glibenclamide binding sites in rat neuronal and cardiac tissue: localization and developmental characteristicsJ A Miller, N L Velayo, R C Dage, et al.
Journal of Cardiovascular Pharmacology|January 1, 1984
Cardiovascular properties of a new cardiotonic agent, MDL 19205R C Dage, L E Roebel, C P Hsieh, et al.
Journal of Cardiovascular Pharmacology|January 1, 1984
In vitro and in vivo assessment of the cardiovascular effects of the cardiotonic drug MDL 19205L E Roebel, R C Dage, H C Cheng, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1993
Comparison of the in vitro and in vivo cardiovascular effects of two structurally distinct Ca++ channel activators, BAY K 8644 and FPL 64176D Rampe, B Anderson, V Rapien-Pryor, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Journal of Cardiovascular Pharmacology|November 1, 1994
Effects of MDL 28,133A, a 5-HT2 receptor antagonist, on platelet aggregation and coronary thrombosis in dogsC P Hsieh, K Sakai, G C Bruns, et al.
Journal of Enzyme Inhibition|January 1, 1989
Interaction of angiotensin I-converting enzyme with two potent tricyclic inhibitorsE Giroux, D W Beight, R C Dage, et al.
The American Journal of Physiology|April 1, 1989
Mitogenesis by serum and PDGF is independent of PI degradation and PKC in VSMCM Kihara, P J Robinson, S H Buck, et al.
Journal of Cardiovascular Pharmacology|February 1, 1987
Effects of enoximone and isobutylmethylxanthine on contractile tension and cyclic nucleotide levels in isolated blood-perfused dog papillary muscleC P Hsieh, T Kariya, R C Dage, et al.
The American Journal of Physiology|December 1, 1991
Parathyroid hormone: an endogenous modulator of cardiac calcium channelsD Rampe, A E Lacerda, R C Dage, et al.
Journal of Cardiovascular Pharmacology|July 1, 1985
Studies on the mechanism of the positive inotropic effect of piroximone in cat papillary muscleH C Cheng, T Kariya, E M Gleason, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1991
High affinity [3H]glibenclamide binding sites in rat neuronal and cardiac tissue: localization and developmental characteristicsJ A Miller, N L Velayo, R C Dage, et al.
Journal of Cardiovascular Pharmacology|January 1, 1984
Cardiovascular properties of a new cardiotonic agent, MDL 19205R C Dage, L E Roebel, C P Hsieh, et al.
Journal of Cardiovascular Pharmacology|January 1, 1984
In vitro and in vivo assessment of the cardiovascular effects of the cardiotonic drug MDL 19205L E Roebel, R C Dage, H C Cheng, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1993
Comparison of the in vitro and in vivo cardiovascular effects of two structurally distinct Ca++ channel activators, BAY K 8644 and FPL 64176D Rampe, B Anderson, V Rapien-Pryor, et al.
Pageof 5